Search clinical trials for: Azelaic acid (Finacea, BAY39-6251)

Total 156 results

LEO Pharma
Bayer

Completed

A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea

Rosacea

United States
LEO Pharma
Bayer

Completed

Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne

Acne Vulgaris

United States
LEO Pharma
Bayer

Completed

Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea

Papulopustular Rosacea

United States
LEO Pharma
Bayer

Completed

Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea

Papulopustular Rosacea

United States
Actavis Inc.

Completed

A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea

Rosacea

United States
Padagis LLC
DPT Laboratories, Ltd.

Completed

Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face

Rosacea

United States
Clinical Research Center of the Carolinas
Bayer

Completed

Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea

Rosacea, Papulopustular

United States
Taro Pharmaceuticals USA

Completed

To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel

Rosacea
Wake Forest University Health Sciences

Not yet recruiting

Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA) ((CCCA))

Central Centrifugal Cicatricial Alopecia

United States
LEO Pharma
Bayer

Completed

Preferences & Treatment Satisfaction Drivers in Rosacea Patients

Rosacea

United States
Derm Research, PLLC
Bayer

Completed

Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH)

Acne Vulgaris | Post Inflammatory Hyperpigmentation

United States
Wake Forest University Health Sciences
Bayer

Completed

Combination Gel and Vascular ND in Mild to Moderate Rosacea

Rosacea

United States
Taro Pharmaceuticals USA

Completed

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea

Rosacea

United States
Wake Forest University

Completed

Azelaic Acid on Demodex Counts in Rosacea

Rosacea

United States
Actavis Inc.

Completed

A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea

Rosacea

United States
Marco Alexandre Dias da Rocha
Bayer; Associacao Fundo de Incentivo a Psicofarmcologia; Fleury

Unknown

The Influence of Peripheral Androgen Conversion at Women Adult Acne

Quality of Life | Acne

Brazil
Galderma R&D

Completed

Split-face Tolerability Comparison Between MetroGel® 1% vs Finacea® 15% in Subjects With Healthy Skin

Skin Manifestations

United States
Galderma R&D

Completed

Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy Skin

Skin Manifestations

United States
Callender Center for Clinical Research

Unknown

Azelaic Acid Versus Hydroquinone in Melasma

Melanosis

United States
Dermatology Specialists Research

Completed

Efficacy of Oral Minocycline (Solodyn) and Oral Minocycline (Solodyn) Plus Azelaic Acid (Finacea) for Acne Rosacea

Rosacea

United States
LEO Pharma
Bayer

Completed

Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea

Papulopustular Rosacea

United States
LEO Pharma
Bayer

Completed

A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis

Perioral Dermatitis

Germany
Medical University of Vienna

Unknown

Azelaic Acid Iontophoresis Versus Topical Azelaic Acid Cream in the Treatment of Melasma (AAI)

Melasma

Austria
Derm Research, PLLC
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

Completed

Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study

Acne Rosacea

United States
LEO Pharma
Bayer

Completed

A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily

Papulopustular Rosacea

Germany
Galderma R&D

Completed

Phase 3 Papulopustular Rosacea Study

Papulopustular Rosacea

United States, Canada
Galderma R&D

Completed

Phase 3 Papulopustular Rosacea Study

Papulopustular Rosacea (PPR)

United States, Canada
LEO Pharma
Bayer

Completed

Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea

Papulopustular Rosacea

United States
LEO Pharma
Bayer

Completed

A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face

Seborrheic Dermatitis on the Face

Germany
LEO Pharma
Bayer

Completed

Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation

Healthy

United States
LEO Pharma
Bayer

Completed

21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation

Healthy

United States
Galderma R&D

Completed

Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea

Erythema | Rosacea

United States
LEO Pharma
Bayer

Completed

Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea

Papulopustular Rosacea

United States
Combined Military Hospital Abbottabad

Completed

Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuvant to Oral Tranexamic Acid in Melasma

Melasma

Pakistan
Centre For International Health
Tribhuvan University, Nepal; NORCE Norwegian Research Centre AS

Active, not recruiting

Vitamin B12, Neurodevelopment and Growth in Nepal (BeLive)

Development | Malnutrition | Vitamin Deficiency

Nepal
Shire

Withdrawn

ARALAST NP Alpha-1 Lung Density Chronic Obstructive Pulmonary Disease-Emphysema (COPD-E) Study

Chronic Obstructive Pulmonary Disease | Alpha1-antitrypsin Deficiency
GlaxoSmithKline

Completed

Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris

Acne Vulgaris

Germany
Bayer
Janssen Research & Development, LLC

Completed

Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention (X-PLORER)

Coronary Artery Disease | Cardiovascular Disease

Belgium, Netherlands
Revolution Medicines, Inc.

Recruiting

Study of RAS(ON) Inhibitor Combinations in Patients With Advanced RAS-mutated NSCLC

Non-Small Cell Lung Cancer, NSCLC | KRAS, NRAS, HRAS-mutated NSCLC | KRAS G12C-mutated Solid Tumors, Lung Cancer | Lung Cancer Stage IV, Advanced Solid Tumor, Cancer

United States
Bayer
Janssen Research & Development, LLC

Completed

Oral Rivaroxaban in Children With Venous Thrombosis (EINSTEINJunior)

Venous Thrombosis

France, United States, Switzerland, Netherlands, Canada, Germany, Austria, Australia, Israel, Italy
Bayer

Completed

An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study

Venous Thromboembolism

United States, Canada
University of Magdeburg
Bayer

Completed

Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin (SKADI)

Acne Vulgaris

Germany
Cairo University

Completed

Combined Salicylic and Azaleic Acid Verus Trichloroacetic Acid 25% Peel in Treatment of Acne

Acne Vulgaris
Bayer
Janssen Research & Development, LLC

Completed

Risk Factors of Outcomes Associated With Disease Progression in Patients With Atrial Fibrillation and Heart Failure (HF) Who Are Receiving a Direct Oral Anticoagulant (Rivaroxaban) (FARAONIC)

Heart Failure

Spain
Bayer

Completed

A Study to Learn About Venous Thromboembolism (VTE) Treatment With Rivaroxaban in Japanese Patients Using a Claims Database

Treatment of Venous Thromboembolism

Japan
Bayer
Janssen Research & Development, LLC

Completed

Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE) (JPMS-XAR-VTE)

Venous Thromboembolism

Japan
Bayer
Janssen Research & Development, LLC

Completed

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region (XANTUS-EL)

Atrial Fibrillation

Colombia, Kazakhstan, Mexico, Russian Federation, Argentina, Azerbaijan, Bahrain, Chile, Egypt, Georgia, Jordan, Kenya, Lebanon, Saudi Arabia, United Arab Emirates, Uruguay, Venezuela
Bayer
Janssen Research & Development, LLC

Completed

Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients (NEURO-XAR)

Stroke | Embolism

Russian Federation
Bayer
Janssen Research & Development, LLC

Completed

Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE) (SOPRANO)

Arthroplasty, Replacement, Knee | Arthroplasty, Replacement, Hip

Russian Federation
Bayer
Janssen Scientific Affairs, LLC

Completed

Satisfaction/Quality of Life With Rivaroxaban in SPAF (Stroke Prevention in Atrial Fibrillation) Indication (SAFARI)

Atrial Fibrillation

France

3

Subscribe